Press releases

Vedi tutto

22 March 2024

TECO and DIESSE announce strategic partnership for the distribution of CHORUS systems and AUTO-DAT in DACH (Germany, Austria and Switzerland)

26 January 2024

Dichbio and DIESSE announce strategic partnership for the distribution of ESR solutions in China 

13 September 2023

DIESSE Biotech Campus - Inauguration today of the most advanced Italy based and European excellence IVD biotechnology centre

8 March 2023

DIESSE announces strategic collaboration with SAIHUB for creating a Data Platform essential for the implementation of artificial intelligence in diagnostic systems

22 December 2022

aeChem grants DIESSE the exclusive access to its international patent that unlocks an innovative detection method on CHORUS immunoassay platforms

25 October 2022

DIESSE announces the launch of new kits for the quantification of Vitamine B12 and Folate on CHORUS system

26 September 2022

DIESSE Diagnostica Senese announces the publication of its first Sustainability Report

1 August 2022

DIESSE announces a strategic partnership with Grifols to distribute tests for biological drug monitoring in Italy

26 July 2022

DIESSE and Menarini Silicon Biosystems Inc. announced strategic partnership to distribute CHORUS TRIO in North America

20 July 2022

DIESSE Diagnostica Senese announces the approval by the Shareholders' Meeting of the transformation into a Benefit Company

21 June 2022

DIESSE makes a collection of E-BIKES available for employee use in order to encourage well-being

9 May 2022

DIESSE a supporto del progetto Pharma and Device Valley è felice dell’avvio della costruzione della piattaforma logistica toscana per le scienze della vita

17 February 2022

ViroGates announces the CE-IVD accreditation of suPARnostic® ELISA on the CHORUS Trio platform marketed by Italy-based DIESSE

6 December 2021

DIESSE and ViroGates announces a development, supply and collaboration agreement for adaption of suPARnostic® ELISA on the Chorus Trio platform

24 September 2021

Test rapidi per la misurazione degli anticorpi Covid-19 a disposizione dei lavoratori del comparto scuola comunale di Siena, in collaborazione con DIESSE e Asp Città di Siena.

23 June 2021

DIESSE announces a partnership with Grifols to develop tests for bioligic drugs monitoring

19 June 2021

REBuilding The Future. Evento di posa della prima pietra del DIESSE BIOTECH CAMPUS

9 March 2021

COVID-19: the alliance between Diesse and TLS produces the diagnostic kit used in clinical trials on monoclonal antibody therapy

19 February 2021

Diesse and AchilleS Vaccines working together for new monoclonal antibody based therapies

29 January 2021

DIESSE LAUNCHES THE SARS-CoV-2 “NEUTRALIZING” Ab, AN IMPORTANT TEST FOR MEASURING VACCINE EFFECTIVENESS

10 December 2020

DIESSE ANNOUNCES THE FIRST SARS-CoV-2 NEUTRALIZING ANTIBODIES RESEARCH KIT, USEFUL FOR MEASURING THE EFFECTIVENESS OF VACCINES

19 November 2020

DIESSE ANNOUNCES A NEW SARS-CoV-2 ANTIGEN TEST

3 November 2020

DIESSE ANNOUNCES THE NEW CONFIGURATION OF ITS CHORUS TRIO IMMUNOMETRIC ASSAY SYSTEM

15 October 2020

DIESSE ANNOUNCES ITS ENTRY INTO VETERINARY MEDICINE WITH THE FIRST INSTRUMENT FOR MEASURING ESR IN ANIMALS

8 October 2020

DIESSE ANNOUNCES A NEW KIT FOR THE DIAGNOSIS OF INFECTION FROM SARS-CoV-2 ON THE CHORUS SYSTEM

31 July 2020

COVID19 Diagnosis: Toscana Life Sciences and Diesse Diagnostica Senese announce strategic alliance for the development of a new kit

30 June 2020

DIESSE CELEBRATES 40TH ANNIVERSARY AND ANNOUNCES NEW VES-MATIC 5 INSTRUMENT

15 June 2020

DIESSE AUTOMATES THE SARS-CoV-2 KIT IN SINGLE-TEST FORMAT ON THE CHORUS INSTRUMENT

24 April 2020

DIESSE READY TO SUPPLY COVID-19 SERIOLOGICAL TESTS

18 March 2020

COVID-19: Spallanzani Institute and Diesse Diagnostica Senese announce an agreement for the development of serological tests.

18 March 2020

Coronavirus, Tuscany at the forefront of the screening effort thanks to Sienese excellence. Kits will be available soon